Gamma knife radiosurgery for arteriovenous malformations: general principles and preliminary results in a Swiss cohort.

Details

Ressource 1Download: smw_148_w14602.pdf (959.75 [Ko])
State: Public
Version: author
License: Not specified
Serval ID
serval:BIB_FCE3EE1A4BAB
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Gamma knife radiosurgery for arteriovenous malformations: general principles and preliminary results in a Swiss cohort.
Journal
Swiss medical weekly
Author(s)
Raboud M., Tuleasca C. (co-first), Maeder P., Schiappacasse L., Marguet M., Daniel R.T., Levivier M.
ISSN
1424-3997 (Electronic)
ISSN-L
0036-7672
Publication state
Published
Issued date
2018
Peer-reviewed
Oui
Volume
148
Pages
w14602
Language
english
Notes
Publication types: Clinical Trial ; Journal Article
Publication Status: epublish
Abstract
Arteriovenous malformations (AVMs) are a type of vascular malformation characterised by an abnormal connection between arteries and veins, bypassing the capillary system. This absence of capillaries generates an elevated pressure (hyperdebit), in both the AVM and the venous drainage, increasing the risk of rupture. Management modalities are: observation, microsurgical clipping, endovascular treatment and radiosurgery. The former can be used alone or in the frame of a multidisciplinary approach. We review our single-institution experience with gamma knife radiosurgery (GKR) over a period of 5 years.
The study was open-label, prospective and nonrandomised. Fifty-seven consecutive patients, benefitting from 64 GKR treatments, were included. All were treated with Leksell Gamma Knife Perfexion (Elekta Instruments, AB, Sweden) between July 2010 and August 2015. All underwent stereotactic multimodal imaging: standard digital subtraction angiography, magnetic resonance imaging and computed tomography angiography. We report obliteration rates, radiation-induced complications and haemorrhages during follow-up course.
The mean age was 46 years (range 13-79 years). The mean follow-up period was 36.4 months (median 38, range 12-75 months). Most common pretherapeutic clinical presentation was haemorrhage (50%). The most common Pollock-Flickinger score was between 1.01 and 1.5 (46%) and Spetzler-Martin grade III (46%). In 39 (60.1%) of cases, GKR was performed as upfront therapeutic option. The mean gross target volume (GTV) was 2.3 ml (median 1.2, range 0.03-11.3 ml). Mean marginal dose was 22.4 Gy (median 24, range 18-24 Gy). The mean prescription isodose volume (PIV) was 2.9 ml (median 1.8, range 0.065-14.6 ml). The overall obliteration rates (all treatments combined) at 12, 24, 36, 48 and 60 months were 4.8, 16.9%, 37.4, 63.6 and 78.4%, respectively. The main predictive factors for complete obliteration were: higher mean marginal dose (23.3 vs 21.0 Gy), lower GTV (mean 1.5 vs 3.5 ml) and absence of previous embolisation (at 60 months 61.8% prior embolisation compared with 82.4% without prior embolisation) (for all p <0.05). Eight (14%) patients experienced complications after GKR. Overall definitive morbidity rate was 3.1%. No patient died from causes related to GKR. However, during the obliteration period, one case of extremely rare fatal haemorrhage occurred.
Radiosurgery is a safe and effective treatment modality for intracranial AVMs in selected cases. It can be used as upfront therapy or in the frame of a combined management. Obliteration rates are high, with minimal morbidity. The treatment effect is progressive and subsequent and regular clinical and radiological follow-up is needed to evaluate this effect.
Keywords
Female, Hemorrhage/etiology, Humans, Intracranial Arteriovenous Malformations/classification, Intracranial Arteriovenous Malformations/diagnostic imaging, Intracranial Arteriovenous Malformations/surgery, Male, Middle Aged, Postoperative Complications, Prospective Studies, Radiosurgery/methods, Switzerland, Treatment Outcome
Pubmed
Web of science
Open Access
Yes
Create date
12/04/2018 16:39
Last modification date
21/11/2022 8:10
Usage data